Study generally supports telehealth for ADHD medication prescribing

New ADHD medication on the horizon
di: Alison Knopf
Pubblicazione: (2026)

Pharmacogenomic testing influenced prescribing in patients with depression
Pubblicazione: (2025)

Meta‐analysis suggests risk of psychosis from stimulant treatment for ADHD
Pubblicazione: (2025)

Umbrella review finds several ADHD treatments efficacious in short term
Pubblicazione: (2026)

Cannabis laws may influence trends in prescribing of psychotropics
Pubblicazione: (2024)

Teens prescribed stimulants for ADHD not likely to have later drug misuse
di: Alison Knopf
Pubblicazione: (2024)

ADHD medications with fewer adverse events would improve outcomes
di: Alison Knopf
Pubblicazione: (2024)

Semaglutide improves outcomes in patients with schizophrenia and medical comorbidities
Pubblicazione: (2025)

Post‐hospital initiation of medication for AUD reduces rehospitalization
Pubblicazione: (2024)

Why a complete medical exam is necessary prior to diagnosing ADHD
di: Alison Knopf
Pubblicazione: (2024)

Decision‐support tool shows promise for treatment retention in depression
Pubblicazione: (2026)

Review of trials finds psychedelics generally well‐tolerated
Pubblicazione: (2024)

Study suggests benefit of continuing antipsychotic during pregnancy
Pubblicazione: (2025)

Study finds semaglutide not associated with higher risk of suicidality
Pubblicazione: (2024)

Study finds association between levonorgestrel exposure, depression
Pubblicazione: (2024)

Study shows improved schizophrenia negative symptoms with xanomeline‐trospium
Pubblicazione: (2025)

Study finds sustained effects of LSD‐assisted therapy on anxiety
Pubblicazione: (2024)

Analysis: Study design contributed to differences in ketamine‐ECT trials
Pubblicazione: (2024)

Study finds no link between prenatal antidepressant exposure and childhood depression
Pubblicazione: (2025)

Study finds gabapentinoid treatment does not elevate risk of self‐harm
Pubblicazione: (2025)

Study of young psychiatric patients shows potential preventive benefit of doxycycline
Pubblicazione: (2026)

Study of children exposed to SSRIs during breastfeeding finds no cognitive risk
Pubblicazione: (2026)

Study: First‐trimester exposure to Z‐drugs not linked to congenital malformations
Pubblicazione: (2026)

Study finds low correspondence between known genetic variations and treatment targets
Pubblicazione: (2025)

Methylphenidate for ADHD found to have effects on stature and BMI
di: Alison Knopf
Pubblicazione: (2026)

Viloxazine moderate dose associated with good ADHD outcomes
di: Alison Knopf
Pubblicazione: (2024)

Researchers find maternal use of ADHD stimulants safe during pregnancy
di: Alison Knopf
Pubblicazione: (2024)

Suicidality and psychotropic drugs: Another perspective
di: Lawrence H. Price
Pubblicazione: (2025)

Liver enzyme levels elevated in healthy users of CBD products
Pubblicazione: (2025)

Exposure to antipsychotics broadly disrupts glucose homeostasis
Pubblicazione: (2025)

Review of GLP‐1 trials finds low incidence of suicide risk
Pubblicazione: (2025)

Climate change and psychopharmacology
di: Lawrence H. Price
Pubblicazione: (2025)

Your Medication Information
Pubblicazione: (2025)

Your Medication Information
Pubblicazione: (2025)

Antidepressant discontinuation: Skepticism and science
di: Lawrence H. Price
Pubblicazione: (2025)

Data on prescription stimulant misuse suggest need for closer screening
Pubblicazione: (2025)